Screener
Praxis Precision Medicines, Inc. PRAX Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Praxis Precision Medicines, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001689548-26-000083
FAQ
- What is Praxis Precision Medicines, Inc.'s debt-to-equity?
- Praxis Precision Medicines, Inc. (PRAX) reported debt-to-equity of 0× in Q2 2026.
- How has Praxis Precision Medicines, Inc.'s debt-to-equity changed year-over-year?
- Praxis Precision Medicines, Inc.'s debt-to-equity decreased by 57.9% year-over-year, from 0× to 0×.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s debt-to-equity?
- Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s debt-to-equity has grown at a -48.3% compound annual growth rate (CAGR), from 0× to 0×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Praxis Precision Medicines, Inc.'s debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude